Cerebrolysin is a neuropeptide preparation used to support brain function, often prescribed for cognitive disorders, stroke recovery, and neurodegenerative diseases.
Overview
Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from porcine brain tissue. It is believed to mimic the effects of nerve growth factors, promoting neuronal survival, repair, and regeneration.
Primarily used in neurological conditions, Cerebrolysin has applications in improving cognitive function, enhancing recovery after stroke, and treating Alzheimer’s disease and other dementias by supporting brain plasticity.
Research
Clinical trials indicate that Cerebrolysin can improve cognitive performance, memory, and functional recovery in patients with stroke and neurodegenerative disorders. Its neuroprotective properties may help reduce neuronal damage and inflammation.
Ongoing research focuses on its efficacy in various neurological diseases, optimal dosing regimens, and long-term safety. While promising, some studies suggest that more extensive trials are needed to fully establish its clinical benefits.
Reviews
There are no reviews yet.